The distinct patterns of differential expression and differential variability between tumor and non-tumor samples, compared to knockout and wild-type samples, imply that dysregulation of clock progression in human cancer is not due solely to the inactivation of one or more clock genes. This evidence concerns the gene CLOCK and cancer.